The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: What the Research Says About Healing and Recovery Yoo Direct Health